HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
+3.04%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$64.4M
AUM Growth
–
Cap. Flow
+$64.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
56.75%
Holding
46
New
33
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$4.64M |
| 2 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$4.57M |
| 3 |
Quest Diagnostics
DGX
|
$4.08M |
| 4 |
Accuray
ARAY
|
$3.89M |
| 5 |
AstraZeneca
AZN
|
$3.89M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 79.6% |
| 2 | Industrials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.64M | 3.37% | +722,314 | New | +$4.64M |
|
|
AUXL
2
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $4.57M | 3.31% | +274,481 | New | +$4.57M |
|
|
3
Quest Diagnostics
DGX
$20.3B
| $4.08M | 2.95% | +67,208 | New | +$4.08M |
|
|
4
Accuray
ARAY
$157M
| $3.89M | 2.82% | +677,749 | New | +$3.89M |
|
|
5
AstraZeneca
AZN
$248B
| $3.89M | 2.82% | +82,239 | New | +$3.89M |
|
|
FRX
6
DELISTED
FOREST LABORATORIES INC
FRX
| $3.5M | 2.54% | +85,382 | New | +$3.5M |
|
7
Humana
HUM
$36.5B
| $3.38M | 2.45% | +40,100 | New | +$3.38M |
|
8
Cardinal Health
CAH
$35.5B
| $3.3M | 2.39% | +69,886 | New | +$3.3M |
|
9
Bio-Techne
TECH
$8.5B
| $2.76M | 2% | +40,000 | New | +$2.76M |
|
10
ANI Pharmaceuticals
ANIP
$2.03B
| $2.55M | 1.85% | +2,244,663 | New | +$2.54M |
|
11
GSK
GSK
$79.9B
| $2.3M | 1.67% | +45,966 | New | +$2.3M |
|
|
SGNT
12
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.16M | 1.57% | +102,922 | New | +$2.16M |
|
13
Orthofix Medical
OFIX
$592M
| $1.92M | 1.39% | +71,200 | New | +$1.92M |
|
14
Elevance Health
ELV
$71.8B
| $1.85M | 1.34% | +22,638 | New | +$1.85M |
|
15
Sanofi
SNY
$121B
| $1.69M | 1.22% | +32,735 | New | +$1.69M |
|
|
WCG
16
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.67M | 1.21% | +30,000 | New | +$1.67M |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $1.63M | 1.18% | +65,588 | New | +$1.63M |
|
|
QLTI
18
DELISTED
QLT Inc
QLTI
| $1.6M | 1.16% | +365,139 | New | +$1.6M |
|
|
AGN
19
DELISTED
Allergan plc
AGN
| $1.58M | 1.15% | +12,524 | New | +$1.58M |
|
|
HMA
20
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $1.57M | 1.14% | +100,000 | New | +$1.57M |
|
|
GIVN
21
DELISTED
GIVEN IMAGING LTD
GIVN
| $1.54M | 1.12% | +109,950 | New | +$1.54M |
|
|
STJ
22
DELISTED
St Jude Medical
STJ
| $1.43M | 1.04% | +31,349 | New | +$1.43M |
|
23
Pacira BioSciences
PCRX
$1.2B
| $1.31M | 0.95% | +45,000 | New | +$1.31M |
|
|
CRTX
24
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
| $865K | 0.63% | +108,168 | New | +$865K |
|
25
Merck
MRK
$210B
| $790K | 0.57% | +17,000 | New | +$790K |
|